Diamond MesoCannula logo

A family-driven development rooted in clinical practice

Jens Ola, Trine, Laila Rigmor and Truls Evjensvold standing together

History

How Diamond MesoCannula came to be

Diamond MesoCannula originated in everyday clinical work within aesthetic medicine.

Over years of hands-on treatments, a recurring issue became clear: injection precision depended too heavily on individual technique.

Even with experience and training, achieving consistent depth, volume and distribution across larger treatment areas was difficult. Small variations in angle, pressure and movement often led to uneven results, particularly in anatomically sensitive regions.

With no existing solution addressing this limitation, the idea of a mechanically guided system emerged. Diamond MesoCannula was not developed as a technical experiment, but as a direct response to a recurring clinical problem.

The concept was first considered for patent protection in 2019 and has since undergone continuous development and evaluation, grounded in clinical use and practical insight.

Clinical foundation

Precision should be structural, not personal

Most skin booster and injectable treatments today rely on single-needle techniques, where outcome depends largely on the practitioner’s manual control. Depth, spacing and symmetry are achieved through repetition and experience, without mechanical guidance.

Diamond MesoCannula was developed to address this limitation. By combining multiple needles in a fixed geometric system, the aim is to reduce variability between treatments and between operators.

The goal is not to replace clinical skill, but to support it – by making precision more predictable and repeatable in practice.

Meet the team

Portrait of Laila Rigmor Evjensvold

Laila Rigmor Evjensvold

Inventor & Clinical Expert · Aesthetic Nurse

Identified the clinical limitations that led to the development of DMC, based on years of hands-on work in aesthetic medicine

Jens Ola Evjensvold

Jens Ola Evjensvold

Technical Advisor · General & Vascular Surgeon

Contributes surgical and anatomical expertise

Portrait of Trine Evjensvold

Trine Evjensvold

CEO & Clinical Lead · Dentist

Leads the clinical and strategic development of the system

Truls Evjensvold

Truls Evjensvold

Medical Advisor · Orthopedic Surgeon

Supports clinical testing and evaluation

Let’s talk about the next step

Diamond MesoCannula is currently in continued development and clinical validation. We are open to dialogue with clinicians, partners and investors with a clear interest in clinical evaluation, development or commercialization.

Get in touch
Portrait of Trine Evjensvold